These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2029515)

  • 1. Peptidyl (acyloxy)methyl ketones and the quiescent affinity label concept: the departing group as a variable structural element in the design of inactivators of cysteine proteinases.
    Krantz A; Copp LJ; Coles PJ; Smith RA; Heard SB
    Biochemistry; 1991 May; 30(19):4678-87. PubMed ID: 2029515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent inactivation of cathepsins S and L by peptidyl (acyloxy)methyl ketones.
    Brömme D; Smith RA; Coles PJ; Kirschke H; Storer AC; Krantz A
    Biol Chem Hoppe Seyler; 1994 May; 375(5):343-7. PubMed ID: 8074807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of cysteine proteases by (acyloxy)methyl ketones using S'-P' interactions.
    Dai Y; Hedstrom L; Abeles RH
    Biochemistry; 2000 May; 39(21):6498-502. PubMed ID: 10828965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of histidine-containing dipeptide affinity-labelling agents. Relative inactivation rates of cathepsins B and L.
    Angliker H; Zumbrunn A; Shaw E
    Int J Pept Protein Res; 1991 Oct; 38(4):346-9. PubMed ID: 1797709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of interleukin-1 beta converting enzyme by peptide (acyloxy)methyl ketones.
    Thornberry NA; Peterson EP; Zhao JJ; Howard AD; Griffin PR; Chapman KT
    Biochemistry; 1994 Apr; 33(13):3934-40. PubMed ID: 8142397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative behaviour of calpain and cathepsin B toward peptidyl acyloxymethyl ketones, sulphonium methyl ketones and other potential inhibitors of cysteine proteinases.
    Pliura DH; Bonaventura BJ; Smith RA; Coles PJ; Krantz A
    Biochem J; 1992 Dec; 288 ( Pt 3)(Pt 3):759-62. PubMed ID: 1471990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo inhibition of cathepsin B by peptidyl (acyloxy)methyl ketones.
    Wagner BM; Smith RA; Coles PJ; Copp LJ; Ernest MJ; Krantz A
    J Med Chem; 1994 Jun; 37(12):1833-40. PubMed ID: 8021922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The properties of peptidyl diazoethanes and chloroethanes as protease inactivators.
    Wikstrom P; Kirschke H; Stone S; Shaw E
    Arch Biochem Biophys; 1989 Apr; 270(1):286-93. PubMed ID: 2930191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calpain inhibitors based on the quiescent affinity label concept: high rates of calpain inactivation with leaving groups derived from N-hydroxy peptide coupling reagents.
    Tripathy R; Ator MA; Mallamo JP
    Bioorg Med Chem Lett; 2000 Oct; 10(20):2315-9. PubMed ID: 11055346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-peptidyl, O-acyl hydroxamates: comparison of the selective inhibition of serine and cysteine proteinases.
    Demuth HU; Schierhorn A; Bryan P; Höfke R; Kirschke H; Brömme D
    Biochim Biophys Acta; 1996 Jul; 1295(2):179-86. PubMed ID: 8695644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptidyl (acyloxy)methanes as quiescent affinity labels for cysteine proteinases.
    Krantz A
    Methods Enzymol; 1994; 244():656-71. PubMed ID: 7845242
    [No Abstract]   [Full Text] [Related]  

  • 12. Synthesis of peptidyl ene diones: selective inactivators of the cysteine proteinases.
    Darkins P; Gilmore BF; Hawthorne SJ; Healy A; Moncrieff H; McCarthy N; McKervey MA; Brömme D; Pagano M; Walker B
    Chem Biol Drug Des; 2007 Mar; 69(3):170-9. PubMed ID: 17441903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cysteinyl proteinases and their selective inactivation.
    Shaw E
    Adv Enzymol Relat Areas Mol Biol; 1990; 63():271-347. PubMed ID: 2407065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inactivation of bovine cathepsin B by novel N-chloro-acetyl-dipeptides: application of the Houghten 'tea bag' methodology to inhibitor synthesis.
    Gilmore BF; Harriott P; Walker B
    Biochem Biophys Res Commun; 2005 Aug; 333(4):1284-8. PubMed ID: 15978544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of the inhibitor properties of dipeptidyl (acyloxy)methyl ketones toward the CaaX proteases.
    Dechert AM; MacNamara JP; Breevoort SR; Hildebrandt ER; Hembree NW; Rea AC; McLain DE; Porter SB; Schmidt WK; Dore TM
    Bioorg Med Chem; 2010 Sep; 18(17):6230-7. PubMed ID: 20696584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Additional peptidyl diazomethyl ketones, including biotinyl derivatives, which affinity-label calpain and related cysteinyl proteinases.
    Wikstrom P; Anagli J; Angliker H; Shaw E
    J Enzyme Inhib; 1992; 6(4):259-69. PubMed ID: 1284963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent and selective inactivation of cysteine proteinases with N-peptidyl-O-acyl hydroxylamines.
    Brömme D; Schierhorn A; Kirschke H; Wiederanders B; Barth A; Fittkau S; Demuth HU
    Biochem J; 1989 Nov; 263(3):861-6. PubMed ID: 2574571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of cathepsin B by peptidyl aldehydes and ketones: slow-binding behavior of a trifluoromethyl ketone.
    Smith RA; Copp LJ; Donnelly SL; Spencer RW; Krantz A
    Biochemistry; 1988 Aug; 27(17):6568-73. PubMed ID: 3219354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel N-peptidyl-O-acyl hydroxamates: selective inhibitors of cysteine proteinases.
    Brömme D; Neumann U; Kirschke H; Demuth HU
    Biochim Biophys Acta; 1993 Oct; 1202(2):271-6. PubMed ID: 8399390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The synthesis, kinetic characterization and application of a novel biotinylated affinity label for cathepsin B.
    Walker B; Cullen BM; Kay G; Halliday IM; McGinty A; Nelson J
    Biochem J; 1992 Apr; 283 ( Pt 2)(Pt 2):449-53. PubMed ID: 1575690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.